US FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Sarclisa added to bortezomib, lenalidomide and dexamethasone (VRd) significantly reduced the risk of disease progression or death compared with VRd alone
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Subscribe To Our Newsletter & Stay Updated
